CTTN and breast cancer: As shown in Figure 2J-2L, CRP2-GFP accumulated in actin- and cortactin-enriched areas located at the cell leading edge, in extending pseudopodia, supporting the idea that CRP2 contributes to the mesenchymal mode of invasion in breast cancer cells.